JDRF Calls for Open Protocols in Diabetes Technology
JDRF Creates 'Open Protocols Initiative' Pushing Industry to Embrace Patient Innovation!
Written by Mike Hoskins on October 25, 2017
For those who've been pushing for more support of do-it-yourself diabetes technology over the last five years or so (crystallized as the #WeAreNotWaiting movement), a huge endorsement came last week when JDRF announced a new initiative encouraging the pharma and device industry to be more collaborative with patient innovators.
On Oct. 18, JDRF announced this new initiative calling for open protocols in emerging Artificial Pancreas (AP) technology as part of its ongoing aim to accelerate the development and commercialization of AP systems that automate insulin delivery. This will include both legal support and financial incentives to motivate the industry to follow Dexcom's recent lead in taking steps toward opening their back-end tech, so that innovators from around the Diabetes Community can build the functionality and apps best suited to patients' lives.
OK, that all may sound like mumbo-jumbo to a lot of people... we get it.
Think of it this way: Instead of the closed systems we have now, where each company makes their own "proprietary" devices that work only with their own hardware, software and apps, companies would go open-source and create code and documentation freely available to the public. This would allow partners and independent developers to build upon their tech, and encourage interoperability of devices and data systems.
Many in our community have been championing this cause for years now , and while JDRF's initiative i Continue reading